Fibroblast growth factor 23‐mediated regulation of osteoporosis: Assessed via Mendelian randomization and in vitro study
Journal of Cellular and Molecular Medicine · 2024-07 · 28 (14)
DOI: 10.1111/jcmm.18551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 25.07.2024. Verfasst von Xiang Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education; Department of Endocrinology, Shandong Provincial Hosp…. Hauptthemen laut MEDLINE: Fibroblast Growth Factor-23, Fibroblast Growth Factors, Mendelian Randomization Analysis, Osteoporosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National key research and development project, Taishan Scholar Construction Project Special Funding.
Abstract (Originalsprache)
Despite numerous investigations on the influence of fibroblast growth factor 23 (FGF23), α‐Klotho and FGF receptor‐1 (FGFR1) on osteoporosis (OP), there is no clear consensus. Mendelian randomization (MR) analysis was conducted on genome‐wide association studies (GWASs)‐based datasets to evaluate the causal relationship between FGF23, α‐Klotho, FGFR1 and OP. The primary endpoint was the odds ratio (OR) of the inverse‐variance weighted (IVW) approach. Furthermore, we stably transfected FGF23‐mimic or siRNA‐FGF23 into human bone marrow mesenchymal stem cells (hBMSCs) in culture and determined its cell proliferation and the effects on osteogenic differentiation. Using MR analysis, we demonstrated a strong correlation between serum FGF23 levels and Heel‐ and femoral neck‐BMDs, with subsequent ORs of 0.919 (95% CI: 0.860–0.983, p = 0.014) and 0.751 (95% CI: 0.587–0.962; p = 0.023), respectively. The expression levels of FGF23 were significantly increased in femoral neck of patients with OP than in the control cohort ( p < 0.0001). Based on our in vitro investigation, after overexpression of FGF23, compared to the control group, the BMSC's proliferation ability decreased, the expression level of key osteogenic differentiation genes (RUNX2, OCN and OSX) significantly reduced, mineralized nodules and ALP activity significantly decreased. After silencing FGF23, it showed a completely opposite trend. Augmented FGF23 levels are causally associated with increased risk of OP. Similarly, FGF23 overexpression strongly inhibits the osteogenic differentiation of hBMSCs, thereby potentially aggravating the pathological process of OP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education; Department of Endocrinology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong,…
- Shandong Key Laboratory of Endocrinology and Lipid Metabolism, Jinan, Shandong, China.
- Shandong Institute of Endocrine and Metabolic Diseases, Jinan, Shandong, China.
- "Chuangxin China" Innovation Base of stem cell and Gene Therapy for endocrine Metabolic diseases, Jinan, Shandong, China.
- Shandong Engineering Laboratory of Prevention and Control for Endocrine and Metabolic Diseases, Jinan, Shandong, China.
- Shandong Engineering Research Center of Stem Cell and Gene Therapy for Endocrine and Metabolic Diseases, Jinan, Shandong, China.
ORCID-Profile: Xiang Zhang, Jin Xu
Förderung
- National Key Research and Development Program of China
- National key research and development project
- Taishan Scholar Construction Project Special Funding
Zitieren
APA
Zhang, X., & Xu, J. (2024). Fibroblast growth factor 23‐mediated regulation of osteoporosis: Assessed via Mendelian randomization and in vitro study. Journal of Cellular and Molecular Medicine, 28(14). https://doi.org/10.1111/jcmm.18551
Vancouver
Zhang X, Xu J. Fibroblast growth factor 23‐mediated regulation of osteoporosis: Assessed via Mendelian randomization and in vitro study. Journal of Cellular and Molecular Medicine. 2024;28(14). doi:10.1111/jcmm.18551
BibTeX
@article{Zhang2024,
author = {Zhang, Xiang and Xu, Jin},
title = {Fibroblast growth factor 23‐mediated regulation of osteoporosis: Assessed via Mendelian randomization and in vitro study},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
volume = {28},
number = {14},
doi = {10.1111/jcmm.18551}
}
EUVIMED